Sandra Silberman
64 works · 13,588 citations · h-index 18
Top works
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
- Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor
- Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
- Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study
- Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies
- Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases with Rearrangements of the Platelet-Derived Growth Factor Receptor Beta
- Management of malignant gastrointestinal stromal tumours
- 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec®)
- Phase II study of imatinib in patients with small cell lung cancer.
- A phase I dose escalation study of epidermal growth factor receptor (EGFR) tyrosine kinase (TK) inhibitor CP-358,774 in patients (pts) with advanced solid tumors
- Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
- TPI-287, a New Taxane Family Member, Reduces the Brain Metastatic Colonization of Breast Cancer Cells
- Imatinib: the first 3 years
- Anthracycline-induced cardiotoxicity — are we about to clear this hurdle?
- The Effect of Tenidap on Cytokines, Acute‐Phase Proteins, and Virus Load in Human Immunodeficiency Virus (HIV)‐Infected Patients: Correlation between Plasma HIV‐1 RNA and Proinflammatory Cytokine Levels
- Imatinib: A targeted clinical drug development
- Mechanisms of hemopoietic and immunological dysfunction induced by lymphocytic choriomeningitis virus
- A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia
- Host-Derived Cells Within Antibody-Dependent Murine Tumors 2 3 4
- A role for the androgen receptor in the treatment of male breast cancer